There is growing evidence that tumour heterogeneity has an imperative role in cancer development, evolution and resistance to therapy. Continuing advancements in biomedical research enable tumour heterogeneity to be observed and studied more critically. As one of the most heterogeneous human cancers, melanoma displays a high level of biological complexity during disease progression. However, much is still unknown regarding melanoma tumour heterogeneity, as well as the role it plays in disease progression and treatment response. This review aims to provide a concise summary of the importance of tumour heterogeneity in melanoma
Introduction: It has long been recognized that tumors are composed of a mosaic of cells and numerous...
Human solid malignancies harbour a heterogeneous set of cells with distinct genotypes and phenotypes...
There is an increasing global interest to support research areas that can assist in understanding di...
There is growing evidence that tumour heterogeneity has an imperative role in cancer development, ev...
Melanoma is a cancer that exhibits one of the most aggressive and heterogeneous features. The incide...
Originally described as interpatient variability, tumour heterogeneity has now been demonstrated to ...
Background Human malignant melanoma is a highly aggressive, heterogeneous and drug-resistant cancer...
Introduction: The increasing incidence of cutaneous melanoma and the still limited effective treatme...
Melanoma is a heterogeneous neoplasm at the histomorphologic, immunophenotypic, and molecular levels...
Two major reasons compel us to study tumour heterogeneity: firstly, it represents the basis of acqui...
Background Alternative methods are required to optimise the clinical insights that may be derived fr...
Targeted therapy of metastatic melanoma with MAPK pathway inhibitors holds great promise but suffers...
Cancer is a leading cause of death in men worldwide and the major cause of cancer related death is d...
Cutaneous malignant melanoma (CMM) is the most lethal form of skin cancer and its incidence has incr...
Heterogeneity of biological structure and function is an impediment to the analysis and treatment of...
Introduction: It has long been recognized that tumors are composed of a mosaic of cells and numerous...
Human solid malignancies harbour a heterogeneous set of cells with distinct genotypes and phenotypes...
There is an increasing global interest to support research areas that can assist in understanding di...
There is growing evidence that tumour heterogeneity has an imperative role in cancer development, ev...
Melanoma is a cancer that exhibits one of the most aggressive and heterogeneous features. The incide...
Originally described as interpatient variability, tumour heterogeneity has now been demonstrated to ...
Background Human malignant melanoma is a highly aggressive, heterogeneous and drug-resistant cancer...
Introduction: The increasing incidence of cutaneous melanoma and the still limited effective treatme...
Melanoma is a heterogeneous neoplasm at the histomorphologic, immunophenotypic, and molecular levels...
Two major reasons compel us to study tumour heterogeneity: firstly, it represents the basis of acqui...
Background Alternative methods are required to optimise the clinical insights that may be derived fr...
Targeted therapy of metastatic melanoma with MAPK pathway inhibitors holds great promise but suffers...
Cancer is a leading cause of death in men worldwide and the major cause of cancer related death is d...
Cutaneous malignant melanoma (CMM) is the most lethal form of skin cancer and its incidence has incr...
Heterogeneity of biological structure and function is an impediment to the analysis and treatment of...
Introduction: It has long been recognized that tumors are composed of a mosaic of cells and numerous...
Human solid malignancies harbour a heterogeneous set of cells with distinct genotypes and phenotypes...
There is an increasing global interest to support research areas that can assist in understanding di...